THUNDERBOLT

ALAMEDA, California, July 22, 2026 Penumbra, Inc. has announced positive results from the THUNDER Investigational Device Exemption (IDE) study,...

ALAMEDA, Calif., July 7, 2026 Penumbra, Inc., a global leader in thrombectomy technologies, has announced the first patient enrollment...

ALAMEDA, Calif., June 11, 2026 Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance...